Bridgewater Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-310,221
| Closed | -$32.7M | – | 1150 |
|
|
2025
Q4 | $32.7M | Sell |
310,221
-203,722
| -40% | -$19.1M | 0.12% | 136 |
|
|
2025
Q3 | $43.1M | Sell |
513,943
-636,779
| -55% | -$52.4M | 0.17% | 93 |
|
|
2025
Q2 | $91.1M | Buy |
1,150,722
+615,856
| +115% | +$49M | 0.37% | 61 |
|
|
2025
Q1 | $48M | Sell |
534,866
-904,564
| -63% | -$84.5M | 0.22% | 93 |
|
|
2024
Q4 | $143M | Sell |
1,439,430
-114,840
| -7% | -$11.8M | 0.66% | 25 |
|
|
2024
Q3 | $177M | Sell |
1,554,270
-247,721
| -14% | -$29.4M | 1% | 16 |
|
|
2024
Q2 | $223M | Sell |
1,801,991
-288,265
| -14% | -$37.1M | 1.16% | 16 |
|
|
2024
Q1 | $276M | Buy |
2,090,256
+133,194
| +7% | +$16.4M | 1.39% | 15 |
|
|
2023
Q4 | $213M | Buy |
1,957,062
+333,814
| +21% | +$34.7M | 1.19% | 18 |
|
|
2023
Q3 | $167M | Buy |
1,623,248
+262,304
| +19% | +$28.3M | 1.01% | 20 |
|
|
2023
Q2 | $157M | Buy |
1,360,944
+447,960
| +49% | +$50.9M | 0.97% | 19 |
|
|
2023
Q1 | $97.1M | Sell |
912,984
-20,781
| -2% | -$2.24M | 0.59% | 36 |
|
|
2022
Q4 | $104M | Sell |
933,765
-531,637
| -36% | -$54.3M | 0.57% | 31 |
|
|
2022
Q3 | $126M | Buy |
1,465,402
+147,055
| +11% | +$13.1M | 0.64% | 27 |
|
|
2022
Q2 | $120M | Buy |
1,318,347
+534,277
| +68% | +$47.4M | 0.51% | 34 |
|
|
2022
Q1 | $64.3M | Buy |
784,070
+393,728
| +101% | +$31M | 0.26% | 74 |
|
|
2021
Q4 | $29.9M | Buy |
390,342
+251,339
| +181% | +$20M | 0.17% | 101 |
|
|
2021
Q3 | $10.4M | Buy |
139,003
+65,706
| +90% | +$5M | 0.06% | 201 |
|
|
2021
Q2 | $5.7M | Buy |
+73,297
| New | +$5.45M | 0.04% | 311 |
|
|
2020
Q2 | – | Sell |
-49,575
| Closed | -$3.64M | – | 470 |
|
|
2020
Q1 | $3.64M | Buy |
+49,575
| New | +$3.9M | 0.07% | 83 |
|
|
2019
Q4 | – | Sell |
-8,270
| Closed | -$664K | – | 547 |
|
|
2019
Q3 | $664K | Buy |
+8,270
| New | +$663K | 0.01% | 246 |
|
|
2018
Q4 | – | Sell |
-116,641
| Closed | -$7.9M | – | 502 |
|
|
2018
Q3 | $7.9M | Sell |
116,641
-81,524
| -41% | -$5.19M | 0.08% | 90 |
|
|
2018
Q2 | $11.5M | Sell |
198,165
-7,253
| -4% | -$409K | 0.11% | 68 |
|
|
2018
Q1 | $10.7M | Buy |
205,418
+44,858
| +28% | +$2.42M | 0.1% | 60 |
|
|
2017
Q4 | $8.62M | Buy |
+160,560
| New | +$8.9M | 0.07% | 57 |
|
|
2017
Q3 | – | Sell |
-13,862
| Closed | -$848K | – | 357 |
|
|
2017
Q2 | $848K | Buy |
+13,862
| New | +$844K | 0.01% | 222 |
|
|
2016
Q3 | – | Sell |
-263,620
| Closed | -$14.5M | – | 373 |
|
|
2016
Q2 | $14.5M | Buy |
263,620
+42,758
| +19% | +$2.28M | 0.18% | 37 |
|
|
2016
Q1 | $11.2M | Buy |
220,862
+57,116
| +35% | +$2.8M | 0.14% | 46 |
|
|
2015
Q4 | $8.25M | Sell |
163,746
-100,084
| -38% | -$5.05M | 0.11% | 82 |
|
|
2015
Q3 | $12.4M | Buy |
263,830
+245,866
| +1,369% | +$13.1M | 0.17% | 52 |
|
|
2015
Q2 | $976K | Buy |
+17,964
| New | +$1.01M | 0.01% | 233 |
|
|
2015
Q1 | – | Sell |
-21,527
| Closed | -$1.17M | – | 375 |
|
|
2014
Q4 | $1.17M | Buy |
21,527
+6,707
| +45% | +$374K | 0.01% | 240 |
|
|
2014
Q3 | $838K | Buy |
+14,820
| New | +$832K | 0.01% | 236 |
|
Other funds holding MRK
VCM
VPM
Bridgewater Associates's MRK Position: Q1 2026 in Review
Bridgewater Associates sold out of Merck (MRK) in Q1 2026, closing a stake of 310,221 shares — an estimated $32.7M sold.
Bridgewater Associates first reported a position in MRK in Q3 2014 and held it in 33 quarters. The position peaked at $276M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bridgewater Associates reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
- Bridgewater Associates sold 310,221 Merck shares in Q1 2026, an estimated $32.7M.
- Bridgewater Associates first reported a position in Merck in Q3 2014 and held it in 33 quarters.
- Bridgewater Associates's Merck position peaked at $276M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.